{"id":"W4383683847","doi":"10.58931/cibdt.2023.117","title":"Therapeutic drug monitoring of biologics in inflammatory bowel disease","year":2023,"lang":"en","type":"article","venue":"Canadian IBD Today","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Therapeutic drug monitoring; Medicine; Vedolizumab; Inflammatory bowel disease; Ulcerative colitis; Monoclonal antibody; Drug; Infliximab; Crohn's disease; Biosimilar; Certolizumab pegol; Pharmacokinetics; Disease; Immunology; Pharmacology; Tumor necrosis factor alpha; Intensive care medicine; Internal medicine; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005406193,0.0004649599,0.00105569,0.001311632,0.0003447984,0.001659803,0.0008735171,0.00148519,0.003977928],"category_scores_gemma":[0.01118375,0.0001590125,0.0007118576,0.001401273,0.0006810618,0.00114726,0.001082434,0.002749899,0.001852975],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001162352,"about_ca_system_score_gemma":0.001561392,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001436886,"about_ca_topic_score_gemma":0.002013214,"domain_scores_codex":[0.9951243,0.002334625,0.0006844096,0.0003162604,0.001379139,0.0001613289],"domain_scores_gemma":[0.991623,0.00345043,0.001760528,0.0002617823,0.002498711,0.0004054815],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007168926,0.0001272489,0.007102667,0.003929229,0.0001577655,0.0004127632,0.0001514179,0.0005533692,0.002133609,0.007195762,0.07628161,0.9012376],"study_design_scores_gemma":[0.0002250289,0.0007381727,0.01538896,0.005536407,0.0002970967,0.002029081,0.0001366792,0.001388159,0.004068487,0.005088459,0.9650483,0.00005520663],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.008529888,0.8966111,0.009885782,0.03395266,0.004809027,0.0001906114,0.000674471,0.0003652049,0.04498125],"genre_scores_gemma":[0.2449752,0.640513,0.04207287,0.03584496,0.01259761,0.0006417186,0.002041127,0.0001696668,0.0211438],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.005406193,"threshold_uncertainty_score":0.02859098,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02555785000156629,"score_gpt":0.2733540377454834,"score_spread":0.2477961877439172,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}